Dave Davies

Right. Now, insurance companies note that there are tests and treatments that are unnecessary or ineffective and that some unscrupulous doctors and other providers pad their income by ordering tests and treatments that they know aren't indicated. I mean, that is a real thing, right? Yeah.

It's interesting that you have a story in which you note that anyone who is having a dispute with their insurance company about a claim, payment for a claim, could get actually internal information from the company about its deliberations including memos, emails, maybe even phone recordings. How do they do this?

It's interesting that you have a story in which you note that anyone who is having a dispute with their insurance company about a claim, payment for a claim, could get actually internal information from the company about its deliberations including memos, emails, maybe even phone recordings. How do they do this?

It's interesting that you have a story in which you note that anyone who is having a dispute with their insurance company about a claim, payment for a claim, could get actually internal information from the company about its deliberations including memos, emails, maybe even phone recordings. How do they do this?

When you were reporting the story about Revlimid, you're doing this research, which you've done so many times, and you're also dealing with the effects of your own illness, the multiple myeloma. I wonder, did you or any of your editors have a concern that this might compromise your objectivity or offer an opening for critics to challenge your reporting?

When you were reporting the story about Revlimid, you're doing this research, which you've done so many times, and you're also dealing with the effects of your own illness, the multiple myeloma. I wonder, did you or any of your editors have a concern that this might compromise your objectivity or offer an opening for critics to challenge your reporting?

When you were reporting the story about Revlimid, you're doing this research, which you've done so many times, and you're also dealing with the effects of your own illness, the multiple myeloma. I wonder, did you or any of your editors have a concern that this might compromise your objectivity or offer an opening for critics to challenge your reporting?

Well, David Armstrong, good luck with your treatment, and thanks for your reporting, and thanks for speaking with us. Well, thanks for having me. I enjoyed it. David Armstrong is a senior reporter for ProPublica. His new story about the high cost of the cancer drug Revlimid is The Price of Remission. We recorded our interview Monday.

Well, David Armstrong, good luck with your treatment, and thanks for your reporting, and thanks for speaking with us. Well, thanks for having me. I enjoyed it. David Armstrong is a senior reporter for ProPublica. His new story about the high cost of the cancer drug Revlimid is The Price of Remission. We recorded our interview Monday.

Well, David Armstrong, good luck with your treatment, and thanks for your reporting, and thanks for speaking with us. Well, thanks for having me. I enjoyed it. David Armstrong is a senior reporter for ProPublica. His new story about the high cost of the cancer drug Revlimid is The Price of Remission. We recorded our interview Monday.

Coming up, David Bianculli reviews a new documentary about the remarkable life of singer-songwriter Janice Ian, whose career dates back to her early teens. This is Fresh Air. Janice Ian, the singer-songwriter who had her first hit record as a teenager in the 1960s, is the subject of a new documentary, Janice Ian, Breaking Silence, now available to stream on demand.

Coming up, David Bianculli reviews a new documentary about the remarkable life of singer-songwriter Janice Ian, whose career dates back to her early teens. This is Fresh Air. Janice Ian, the singer-songwriter who had her first hit record as a teenager in the 1960s, is the subject of a new documentary, Janice Ian, Breaking Silence, now available to stream on demand.

Coming up, David Bianculli reviews a new documentary about the remarkable life of singer-songwriter Janice Ian, whose career dates back to her early teens. This is Fresh Air. Janice Ian, the singer-songwriter who had her first hit record as a teenager in the 1960s, is the subject of a new documentary, Janice Ian, Breaking Silence, now available to stream on demand.

Our TV critic David Bianculli has this review.

Our TV critic David Bianculli has this review.

Our TV critic David Bianculli has this review.

David Bianculli is a professor of television studies at Rowan University. He reviewed Janice Ian, Breaking Silence, now available on many streaming sites to view on demand. On tomorrow's show, writer Amy LaRocca joins us to talk about her new book, How to Be Well, a guide drawn from her search for balance in a world obsessed with wellness.

David Bianculli is a professor of television studies at Rowan University. He reviewed Janice Ian, Breaking Silence, now available on many streaming sites to view on demand. On tomorrow's show, writer Amy LaRocca joins us to talk about her new book, How to Be Well, a guide drawn from her search for balance in a world obsessed with wellness.

David Bianculli is a professor of television studies at Rowan University. He reviewed Janice Ian, Breaking Silence, now available on many streaming sites to view on demand. On tomorrow's show, writer Amy LaRocca joins us to talk about her new book, How to Be Well, a guide drawn from her search for balance in a world obsessed with wellness.

From fitness fads to mental health trends, she tries to unpack what it really means to take care of ourselves. I hope you can join us. Our interviews and reviews are produced and edited by Phyllis Myers, Anne-Marie Baldonado, Lauren Krenzel, Teresa Madden, Monique Nazareth, Thea Chaloner, Susan Yakundi, and Anna Bauman. Our digital media producer is Mali Sivinesper.